Reversible Tumor Progression Induced by a Dexamethasone Course for Severe COVID-19 during Immune Checkpoint Inhibitor Treatment

Reversible Tumor Progression Induced by a Dexamethasone Course for Severe COVID-19 during Immune Checkpoint Inhibitor Treatment

Immunotherapies and immune checkpoint inhibitors (ICI) represent the latest revolution in oncology. Several studies have reported an association between the use of corticosteroids and poorer outcomes for patients treated with ICIs. However, it has been never established whether corticoid-induced tum...

Full description

Bibliographic Details
Main Authors: Paul Gougis, Baptiste Abbar, Julie Benzimra, Aurore Vozy, Jean-Philippe Spano, Luca Campedel
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Diagnostics
Subjects:
immunotherapy
immune checkpoint inhibitors
COVID-19
pseudoprogression
corticosteroids
Online Access:https://www.mdpi.com/2075-4418/12/8/1933

Internet

https://www.mdpi.com/2075-4418/12/8/1933

Similar Items